Business
Why did the Exopharm (ASX:EX1) share price surge 12% today?
The Exopharm Ltd (ASX: EX1) share price rocketed today after the company announced positive clinical trial results for its regenerative medical product, Plexaris.
At market close, the Exopharm share price is up by 12.93% today to 65 cents per share.
Exopharm is a biopharmaceutical company focused on developing regenerative medicine. It’s currently investigating the therapeutic potential of two products, Plexaris and Cevaris, in treating osteoarthritis.
The company was undergoing clinical trials to see if the medicine can restore arthritic cell tissue in rats. These clinical trials showed that the drugs had no adverse affects and were safe to trial on humans, however they also showed that drugs’ efficacy was limited to milder…
-
Business23 hours agoHow to build a $250,000 passive income portfolio starting from zero
-
Noosa News22 hours agoDrivers call out bad manners and most hated acts on Queensland roads
-
Business22 hours agoGuess who just bought $5 million worth of Domino’s Pizza shares?
-
Noosa News22 hours agoCoochin Fields developer asked to explain shortfalls in tourist park proposal